Wyeth: Transaction Processing Services

Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies.

As a leader in the discovery, development, manufacturing and marketing of pharmaceuticals, vaccines, biotechnology products and non-prescription medications across a wide range of therapeutic areas, its products are sold in more than 140 countries. The New Jersey-based company employs more than 50,000 people on five continents. In 2004, Wyeth reported net revenues of $17.4 billion and net income of more than $3.5 billion.

To receive more Client Successes, sign up for My Outlook, your single e-mail source for all of Accenture's latest ideas and innovation, personalized specifically to your business interests and the industry issues you face.

On its journey to high performance, Wyeth has made profound changes to its business model.

Accenture had played an important role in Wyeth's success, successfully helping to re-engineer its research and development processes. Wyeth now wanted to generate a similar level of performance in its later drug development processes. To do this, the company first needed to improve its clinical data management capabilities.

The answer was unheard of in the industry: Wyeth wanted Accenture to take over its entire clinical data management operation for a period of 10 years. Large-scale transaction processing was not one of Wyeth's core competencies—nor should it have been. Accenture, on the other hand, was widely known for delivering technology-driven, transaction processing services and managing successful, large-scale process transformations—and Wyeth knew, first-hand, of Accenture's commitment to helping its clients become high-performance businesses.

Accenture quickly set out to work with Wyeth to establish a first-of-its-kind business process outsourcing arrangement for the life sciences industry.

Under the agreement, Accenture is redesigning and implementing a host of new clinical data management practices for Wyeth. In addition, Accenture has taken over the management of Wyeth's 175 clinical data management employees and operations. Guided by its global delivery approach, Accenture is complementing that workforce with an additional 400 skilled personnel from the Accenture Global Delivery Centers, backed by a strong governance structure.

In the area of transaction processing, the team relied heavily on Accenture's proprietary, standardized and repeatable processes. For Wyeth, the Accenture team is applying this proven know-how to manage the processing of all the clinical data associated with more than three million case report forms each year.

Accenture—confident in its abilities to bring value to Wyeth's clinical data management requirements—has agreed to base a portion of its own compensation on its achievement of certain performance objectives.

The team expects to achieve such impressive results because it is developing world-class practices in a number of key areas. These include:

• Project and resource management
• Protocol development and management
• Site selection and study start-up
• Site management
• Data entry/cleaning
• Analysis and reporting

In short, Accenture is helping Wyeth achieve higher levels of integration, productivity, collaboration and business performance. With Accenture at its side, Wyeth is well positioned to continue developing the drug therapies that address the most critical health care needs of millions of people around the world.

To receive more Client Successes, sign up for My Outlook, your single e-mail source for all of Accenture's latest ideas and innovation, personalized specifically to your business interests and the industry issues you face.